-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Holds a Working Meeting for Participants in the Talent-Driven Enterprise Development Program
Category:
发布时间：2023-08-18
【概要描述】
A lasting enterprise hinges on talent. On August 18, the Shijiazhuang Sihua Pharmaceutical Group held an awards ceremony in the R&D Center Auditorium to recognize individuals selected for the Group’s Talent-Driven Enterprise Development Program, during which the list of those included in the program was announced.
“A thriving enterprise for the ages hinges on talent.” On August 18, the Shijiazhuang Sihua Pharmaceutical Group held an awards ceremony in the R&D Center Auditorium to recognize individuals selected for the Group’s Talent-Driven Enterprise Development Program, during which the list of those designated for the program was officially announced.
Group leaders Qu Jiguang, Su Xuejun, Wu Hengyao, and others attended the meeting, which was chaired by Su Xuejun.
Tian Pengmei, Executive President of the Group and General Manager of the Strategic Development and Human Resources Center, delivered a work report on the Talent-Driven Enterprise Initiative to the conference. Tian Pengmei noted that, in light of the Group’s industrial landscape and future development, the Strategic Development and Human Resources Center, in close alignment with the Group’s actual operations and management practices, has formulated and refined the relevant management systems and specific measures for the Talent-Driven Enterprise Initiative. Through a structured process involving departmental screening, center-level recommendations, and review by the Leading Group, a total of 249 employees have been identified at various levels as candidates for cultivation under the initiative. The Talent-Driven Enterprise Initiative has been endorsed by the Municipal Party Committee’s Leading Group for Talent Work and designated as a key project for Shijiazhuang’s “Talent-Driven City” initiative for 2023. It is expected to boost the enthusiasm and creativity of the Group’s core personnel, optimize the knowledge and age profile of the management team, invigorate the management workforce, and enhance the overall effectiveness of corporate operations and management. Over the next three to five years, the Group will intensify the development and training of these key talents, thereby ensuring a steady and sustainable supply of talent to support the Group’s long-term growth.
At the meeting, Su Xuejun, Chairman of the Group, announced the decision to include the Group in the Talent-Driven Enterprise Development Program. Thirty representatives of the program’s trainees then took to the stage one by one, where they were presented with certificates of honor for inclusion in the professional talent pool by Group leaders Qu Jiguang, Su Xuejun, Wu Hengyao, Han Shuqin, Shi Jianhui, and Li Weimin, prompting enthusiastic applause from the audience. Yang Yi from the Quality Management Center delivered a speech on behalf of the program’s trainees.
Qu Jiguang, Chairman of the Group’s Board of Directors, extended warm congratulations to those selected for the Talent-Driven Enterprise Development Program. He noted that, after more than two decades of arduous effort, the Group has grown from an obscure, workshop-style small enterprise into a top-100 pharmaceutical company and a publicly listed firm. The company has undergone a transformative evolution in terms of business scale, core competitiveness, social influence, and employee well-being, achieving remarkable results that have drawn widespread attention within the industry and earning the recognition and respect of Party committees at all levels, government authorities, and various sectors of society. To ensure the continued legacy and build a century-old enterprise, it is essential that successive generations of Sihua employees carry forward the torch and strive tirelessly toward this goal.
Standing at a new historical juncture, the rapid development of Shijiazhuang Sihua Pharmaceutical Group has provided a broad platform for young talents to showcase their abilities. Qu Jiguang emphasized the need to fully recognize the importance of implementing the talent-strengthening strategy and building a high-caliber talent pipeline, with the goal of cultivating and expanding an outstanding team of professionals who embrace the corporate culture, possess strong work capabilities, and demonstrate both moral integrity and professional competence, thereby ensuring the sustainable development of Sihua’s endeavors. It is essential to take a holistic approach to developing high-level, managerial, and skilled talent pools, strengthening the recruitment, training, and deployment of top talent, and mastering the “combined punch” of identifying, cherishing, utilizing, accommodating, and attracting talent. A long-term mechanism for talent development must be established, with due emphasis on discovering and identifying talent on the front lines of production, operations, and management, and on fostering the intrinsic motivation for building and elevating the talent pipeline. At the same time, it is crucial to balance the company’s long-term development with its phased talent needs, so as to provide systematic talent support for the group’s growth. Furthermore, dynamic management of talent pipeline development should be improved, adhering to an evaluation framework centered on quality, performance, and contribution, ensuring that the best are rewarded while underperforming individuals are phased out, and that everyone is placed in a role where they can fully utilize their talents.
The meeting called on all talented individuals across the Group to remain steadfast in their confidence, unite as one in purpose and spirit, work diligently and tenaciously, strive to lead by example, and live up to the expectations of the times, their prime years, and the enterprise. They are urged to integrate learning, reflection, and action into their daily work, hone their skills through practical experience, and grow stronger in the process—thereby taking the lead, setting an exemplary standard, and making meaningful contributions to the Group’s innovative, high-quality development. In growing and advancing together with the enterprise, they should realize their personal value and secure a bright future, carry forward the torch of the Group’s continued development, and demonstrate the commitment and proactive role of the Four Pharmaceutical professionals in accelerating the high-quality development of Shijiazhuang’s biopharmaceutical industry and speeding its transformation into a cluster worth hundreds of billions of yuan.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091